Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
    • Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
      • 1-Minute Consult
      • Commentary
      • Current Drug Therapy
      • Editorial
      • Guidelines to Practice
      • Interpreting Key Trials
      • Letter to the Editor
      • Review
      • Smart Testing
      • Symptoms to Diagnosis
      • The Clinical Picture
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
  • COVID-19
    • Curbside Consults Overview
    • Pulmonary/ICU
    • Patient Subsets & Specific Organ Involvement
    • Therapies
    • Imaging & Procedures
    • Patients with Underlying Disease
    • Virus Background & Testing
    • Healthcare System Practice
  • Conference Coverage
    • ASH Annual Meeting
    • AHA Sessions 2020
    • IDWeek 2020
    • CHEST 2020
    • ADA 2020
    • ACC 2020
  • Advertise
    • Media Kit
    • Contact
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
    • Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
  • COVID-19
    • Curbside Consults Overview
    • Pulmonary/ICU
    • Patient Subsets & Specific Organ Involvement
    • Therapies
    • Imaging & Procedures
    • Patients with Underlying Disease
    • Virus Background & Testing
    • Healthcare System Practice
  • Conference Coverage
    • ASH Annual Meeting
    • AHA Sessions 2020
    • IDWeek 2020
    • CHEST 2020
    • ADA 2020
    • ACC 2020
  • Advertise
    • Media Kit
    • Contact
Review

Serotonin syndrome: Preventing, recognizing, and treating it

Robert Z. Wang, MD, Vishal Vashistha, MD, Sukhdeep Kaur, MBBS and Nathan W. Houchens, MD
Cleveland Clinic Journal of Medicine November 2016, 83 (11) 810-816; DOI: https://doi.org/10.3949/ccjm.83a.15129
Robert Z. Wang
Department of Family Medicine, State University of New York Downstate Medical Center, Brooklyn
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vishal Vashistha
Department of Internal Medicine, Cleveland Clinic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: vashisv@ccf.org
Sukhdeep Kaur
Dayanand Medical College and Hospital, Ludhiana, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nathan W. Houchens
Department of Internal Medicine, University of Michigan, Ann Arbor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

As the use of serotonergic agents to treat depression has increased, so too has the incidence of serotonin syndrome. We identify the common agents implicated in serotonin syndrome and the clinical tools to diagnose, manage, and prevent serotonergic toxicity.

  • Copyright © 2016 The Cleveland Clinic Foundation. All Rights Reserved.
View Full Text

REFERENCES

  1. ↵
    1. Mojtabai R,
    2. Olfson M
    . National trends in long-term use of antidepressant medications: results from the US National Health and Nutrition Examination Survey. J Clin Psychiatry 2014; 75:169–177.
    OpenUrlCrossRefPubMed
  2. ↵
    1. Watson WA,
    2. Litovitz TL,
    3. Rodgers GC Jr.,
    4. et al
    . 2002 Annual Report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med. 2003;21:353–421.
    OpenUrlCrossRefPubMed
  3. ↵
    1. Lai MW,
    2. Klein-Schwartz W,
    3. Rodgers GC,
    4. et al
    . 2005 Annual Report of the American Association of Poison Control Centers’ national poisoning and exopsure database. Clin Toxicol (Phila) 2006; 44:803–932.
    OpenUrlCrossRefPubMed
  4. ↵
    1. Gillman PK
    . The serotonin syndrome and its treatment. J Psychopharmacol 1999; 13:100–109.
    OpenUrlCrossRefPubMed
  5. ↵
    1. Isbister GK,
    2. Buckley NA
    . The pathophysiology of serotonin toxicity in animals and humans: implications for diagnosis and treatment. Clin Neuropharmacol 2005; 28:205–214.
    OpenUrlCrossRefPubMed
  6. ↵
    1. Woytowish MR,
    2. Maynor LM
    . Clinical relevance of linezolid-associated serotonin toxicity. Ann Pharmacother 2013; 47:388–397.
    OpenUrlCrossRefPubMed
  7. ↵
    1. Lee DO,
    2. Lee CD
    . Serotonin syndrome in a child associated with erythromycin and sertraline. Pharmacotherapy 1999; 19:894–896.
    OpenUrlCrossRefPubMed
    1. Gillman PK
    . Triptans, serotonin agonists, and serotonin syndrome (serotonin toxicity): a review. Headache 2010; 50:264–272.
    OpenUrlCrossRefPubMed
  8. ↵
    1. Isbister GK,
    2. Buckley NA,
    3. Whyte IM
    . Serotonin toxicity: a practical approach to diagnosis and treatment. Med J Aust 2007; 187:361–365.
    OpenUrlPubMed
  9. ↵
    1. Mowry JB,
    2. Spyker DA,
    3. Cantilena LR Jr.,
    4. McMillan N,
    5. Ford M
    . 2013 Annual Report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 31st Annual Report. Clin Toxicol (Phila) 2014; 52:1032–1283.
    OpenUrlCrossRefPubMed
  10. ↵
    1. Dunkley EJ,
    2. Isbister GK,
    3. Sibbritt D,
    4. Dawson AH,
    5. Whyte IM
    . The Hunter serotonin toxicity criteria: simple and accurate diagnostic decision rules for serotonin toxicity. QJM 2003; 96:635–642.
    OpenUrlCrossRefPubMed
  11. ↵
    1. Karkare SU,
    2. Bhattacharjee S,
    3. Kamble P,
    4. Aparasu R
    . Prevalence and predictors of antidepressant prescribing in nursing home residents in the United States. Am J Geriatr Pharmacother 2011; 9:109–119.
    OpenUrlCrossRefPubMed
  12. ↵
    1. Weissman J,
    2. Meyers BS,
    3. Ghosh S,
    4. Bruce ML
    . Demographic, clinical, and functional factors associated with antidepressant use in the home healthcare elderly. Am J Geriatr Psychiatry 2011; 19:1042–1045.
    OpenUrlCrossRefPubMed
  13. ↵
    1. Caughey GE,
    2. Roughead EE,
    3. Shakib S,
    4. Vitry AI,
    5. Gilbert AL
    . Co-morbidity and potential treatment conflicts in elderly heart failure patients: a retrospective, cross-sectional study of administrative claims data. Drugs Aging 2011; 28:575–581.
    OpenUrlPubMed
  14. ↵
    1. Iqbal MM,
    2. Basil MJ,
    3. Kaplan J,
    4. Iqbal MT
    . Overview of serotonin syndrome. Ann Clin Psychiatry 2012; 24:310–318.
    OpenUrlPubMed
  15. ↵
    1. Mason PJ,
    2. Morris VA,
    3. Balcezak TJ
    . Serotonin syndrome. Presentation of 2 cases and review of the literature. Medicine (Baltimore) 2000; 79:201–209.
    OpenUrlCrossRefPubMed
  16. ↵
    1. Prakash S,
    2. Patel V,
    3. Kakked S,
    4. Patel I,
    5. Yadav R
    . Mild serotonin syndrome: a report of 12 cases. Ann Indian Acad Neurol 2015; 18:226–230.
    OpenUrl
  17. ↵
    1. Davies O,
    2. Batajoo-Shrestha B,
    3. Sosa-Popoteur J,
    4. Olibrice M
    . Full recovery after severe serotonin syndrome, severe rhabdomyolysis, multi-organ failure and disseminated intravascular coagulopathy from MDMA. Heart Lung 2014; 43:117–119.
    OpenUrl
  18. ↵
    1. Pedavally S,
    2. Fugate JE,
    3. Rabinstein AA
    . Serotonin syndrome in the intensive care unit: clinical presentations and precipitating medications. Neurocrit Care 2014; 21:108–113.
    OpenUrlCrossRefPubMed
  19. ↵
    1. Boyer EW,
    2. Shannon M
    . The serotonin syndrome. N Engl J Med 2005; 352:1112–1120.
    OpenUrlCrossRefPubMed
  20. ↵
    1. Velamoor VR,
    2. Norman RM,
    3. Caroff SN,
    4. Mann SC,
    5. Sullivan KA,
    6. Antelo RE
    . Progression of symptoms in neuroleptic malignant syndrome. J Nerv Ment Dis 1994; 182:168–173.
    OpenUrlCrossRefPubMed
  21. ↵
    1. Isbister GK,
    2. Hackett LP,
    3. Dawson AH,
    4. Whyte IM,
    5. Smith AJ
    . Moclobemide poisoning: toxicokinetics and occurrence of serotonin toxicity. Br J Clin Pharmacol 2003; 56:441–450.
    OpenUrlCrossRefPubMed
  22. ↵
    1. Graudins A,
    2. Stearman A,
    3. Chan B
    . Treatment of the serotonin syndrome with cyproheptadine. J Emerg Med 1998; 16:615–619.
    OpenUrlCrossRefPubMed
  23. ↵
    1. Lappin RI,
    2. Auchincloss EL
    . Treatment of the serotonin syndrome with cyproheptadine. N Engl J Med 1994; 331:1021–1022.
    OpenUrlCrossRefPubMed
  24. ↵
    1. Gillman PK
    . Successful treatment of serotonin syndrome with chlorpromazine. Med J Aust 1996; 165:345–346.
    OpenUrlPubMed
  25. ↵
    1. Buckley NA,
    2. Dawson AH,
    3. Isbister GK
    . Serotonin syndrome. BMJ 2014; 348:g1626.
    OpenUrlFREE Full Text
  26. ↵
    1. Nisijima K,
    2. Shioda K,
    3. Yoshino T,
    4. Takano K,
    5. Kato S
    . Diazepam and chlormethiazole attenuate the development of hyperthermia in an animal model of the serotonin syndrome. Neurochem Int 2003; 43:155–164.
    OpenUrlCrossRefPubMed
  27. ↵
    1. Nisijima K,
    2. Yoshino T,
    3. Yui K,
    4. Katoh S
    . Potent serotonin (5-HT)(2A) receptor antagonists completely prevent the development of hyperthermia in an animal model of the 5-HT syndrome. Brain Res 2001; 890:23–31.
    OpenUrlCrossRefPubMed
  28. ↵
    1. Micca JL,
    2. Ruff D,
    3. Ahl J,
    4. Wohlreich MM
    . Safety and efficacy of duloxetine treatment in older and younger patients with osteoarthritis knee pain: a post hoc, subgroup analysis of two randomized, placebo-controlled trials. BMC Musculoskelet Disord 2013; 14:137.
    OpenUrlCrossRefPubMed
    1. Smith EM,
    2. Pang H,
    3. Cirrincione C,
    4. et al
    5. Alliance for Clinical Trials in Oncology
    . Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial. JAMA 2013; 309:1359–1367.
    OpenUrlCrossRefPubMed
  29. ↵
    1. Lunn MP,
    2. Hughes RA,
    3. Wiffen PJ
    . Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia. Cochrane Database Syst Rev 2014; 1:CD007115.
    OpenUrlPubMed
  30. ↵
    1. Caughey GE,
    2. Roughead EE,
    3. Shakib S,
    4. McDermott RA,
    5. Vitry AI,
    6. Gilbert AL
    . Comorbidity of chronic disease and potential treatment conflicts in older people dispensed antidepressants. Age Ageing 2010; 39:488–494.
    OpenUrlCrossRefPubMed
  31. ↵
    1. Gury C,
    2. Cousin F
    . Pharmacokinetics of SSRI antidepressants: half-life and clinical applicability. Encephale 1999; 25:470–476. French.
    OpenUrlPubMed

This article requires you to have a ccjm.org account to view the full text. If you already have an account, you may log in below to view this article along with all other CCJM content. If you do not have an account, register here. It’s free!

Log in using your username and password

Forgot your user name or password?
PreviousNext
Back to top

Registration is Now Required for Free Access to CCJM Content

Register once and log in for full access to articles and content. Click “Register” in the upper right corner and follow the simple instructions to create a new account.

If you are using a mobile device, click on the settings icon to access the Register link.

In this issue

Cleveland Clinic Journal of Medicine: 83 (11)
Cleveland Clinic Journal of Medicine
Vol. 83, Issue 11
1 Nov 2016
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Cleveland Clinic Journal of Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Serotonin syndrome: Preventing, recognizing, and treating it
(Your Name) has sent you a message from Cleveland Clinic Journal of Medicine
(Your Name) thought you would like to see the Cleveland Clinic Journal of Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
3 + 16 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Serotonin syndrome: Preventing, recognizing, and treating it
Robert Z. Wang, Vishal Vashistha, Sukhdeep Kaur, Nathan W. Houchens
Cleveland Clinic Journal of Medicine Nov 2016, 83 (11) 810-816; DOI: 10.3949/ccjm.83a.15129

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Serotonin syndrome: Preventing, recognizing, and treating it
Robert Z. Wang, Vishal Vashistha, Sukhdeep Kaur, Nathan W. Houchens
Cleveland Clinic Journal of Medicine Nov 2016, 83 (11) 810-816; DOI: 10.3949/ccjm.83a.15129
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Linkedin Share Button

Jump to section

  • Article
    • ABSTRACT
    • WHAT IS SEROTONIN SYNDROME?
    • WHO IS AT RISK OF SEROTONIN SYNDROME?
    • HOW DOES IT PRESENT?
    • HOW DO WE DIAGNOSE SEROTONIN SYNDROME?
    • HOW CAN WE TREAT SEROTONIN SYNDROME?
    • HOW CAN WE PREVENT SEROTONIN SYNDROME?
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Triptan and ergotamine overdoses in the United States: Analysis of the National Poison Data System
  • Hypertensive crisis following the administration of tedizolid: possible serotonin syndrome
  • Case 2: Agitation and Abnormal Movements in a 14-year-old Boy
  • Serotonin syndrome caused by drug to drug interaction between escitalopram and dextromethorphan
  • Serotonin syndrome (November 2016)
  • Google Scholar

More in this TOC Section

  • Perioperative management of pregnant women undergoing nonobstetric surgery
  • Long-term consequences of prematurity
  • Autonomous sensory meridian response: Your patients already know, do you?
Show more Review

Similar Articles

Subjects

  • Mental Health
  • Neurology
  • Emergency Medicine
  • Drug Therapy

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit
  • Advertise Contact

Info For

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • Advertisers
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2021 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire